Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | MGAM | O43451 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | SI | P14410 | 1/20 | 0.36 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.36 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1639253 | 1.00 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10GLO1MAPT | |
| SCHEMBL1655798 | 0.83 | TSHR (0.48) | ALDH1A1LMNAHSD17B10GLO1MAPT | |
| SCHEMBL725208 | 0.82 | ALDH1A1 (0.52) | ALDH1A1LMNAHSD17B10GLO1MAPT | |
| SCHEMBL6906507 | 0.82 | ALDH1A1 (0.52) | ALDH1A1LMNAHSD17B10GLO1MAPT | |
| SCHEMBL2434549 | 0.80 | ALDH1A1 (0.50) | ALDH1A1LMNAMAPTHPGDL3MBTL1 | |
| SCHEMBL6943196 | 0.79 | ALDH1A1 (0.50) | ALDH1A1LMNAHSD17B10MAPTALOX15 | |
| SCHEMBL28391087 | 0.79 | ALDH1A1 (0.50) | ALDH1A1LMNAHSD17B10MAPTALOX15 | |
| SCHEMBL15744779 | 0.78 | ALDH1A1 (0.48) | ALDH1A1LMNAHSD17B10GLO1MAPT | |
| SCHEMBL2174954 | 0.77 | SMN1; SMN2 (0.39) | ALDH1A1TSHRKMT2A | |
| SCHEMBL12150070 | 0.77 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10ALOX15MGAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10246402-B2 | Fruity odorant | FIRMENICH SA (CH) | 2019-04-02 | — | — | US | claimed |
| US-20190077743-A1 | FRUITY ODORANT | FIRMENICH SA (CH) | 2019-03-14 | — | — | US | claimed |
| US-20180208540-A1 | FRUITY ODORANT | FIRMENICH SA (CH) | 2018-07-26 | — | — | US | claimed |
| US-20110097291-A1 | FRUITY ODORANT | FIRMENICH SA (CH) | 2011-04-28 | — | — | US | claimed |
| EP-1494659-B1 | PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-KETOALKANOIC ACID ESTER OR -AMIDE AND LACTIC ACID OR A LACTIC ACID SALT | CRITICAL THERAPEUTICS INC (US) | 2005-10-12 | — | — | EP | claimed |
| EP-1494659-A1 | PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-KETOALKANOIC ACID ESTER OR -AMIDE AND LACTIC ACID OR A LACTIC ACID SALT | Critical Therapeutics, Inc. (US) | 2005-01-12 | — | — | EP | claimed |
| US-20030232884-A1 | New pharmaceutical formulation | CRITICAL THERAPEUTICS, INC. | 2003-12-18 | — | — | US | claimed |
| WO-2003088955-A1 | PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-KETOALKANOIC ACID ESTER OR -AMINE AND LACTIC ACID OR A LACTIC ACID SALT | CRITICAL THERAPEUTICS, INC. (US) | 2003-10-30 | — | — | WO | claimed |
| US-10766850-B2 | Fruity odorant | FIRMENICH SA (CH) | 2020-09-08 | — | — | US | disclosed |
| US-10246402-B2 | Fruity odorant | FIRMENICH SA (CH) | 2019-04-02 | — | — | US | disclosed |
| US-20190077743-A1 | FRUITY ODORANT | FIRMENICH SA (CH) | 2019-03-14 | — | — | US | disclosed |
| US-20180208540-A1 | FRUITY ODORANT | FIRMENICH SA (CH) | 2018-07-26 | — | — | US | disclosed |
| US-9957221-B2 | Fruity odorant | FIRMENICH SA (CH) | 2018-05-01 | — | — | US | disclosed |
| CN-102740706-A | Compositions comprising pyruvate for companion animals and methods of use thereof | HILLS PET NUTRITION INC | 2012-10-17 | — | — | CN | disclosed |
| US-20060057070-A1 | Albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use | MEDICAL UNIVERSITY OF OHIO AT TOLEDO | 2006-03-16 | — | — | US | disclosed |
| EP-1494659-B1 | PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-KETOALKANOIC ACID ESTER OR -AMIDE AND LACTIC ACID OR A LACTIC ACID SALT | CRITICAL THERAPEUTICS INC (US) | 2005-10-12 | — | — | EP | disclosed |
| US-20050187139-A1 | Albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use | MEDICAL COLLEGE OF OHIO | 2005-08-25 | — | — | US | disclosed |
| EP-1494659-A1 | PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-KETOALKANOIC ACID ESTER OR -AMIDE AND LACTIC ACID OR A LACTIC ACID SALT | Critical Therapeutics, Inc. (US) | 2005-01-12 | — | — | EP | disclosed |
| US-20030232884-A1 | New pharmaceutical formulation | CRITICAL THERAPEUTICS, INC. | 2003-12-18 | — | — | US | disclosed |
| WO-2003088955-A1 | PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-KETOALKANOIC ACID ESTER OR -AMINE AND LACTIC ACID OR A LACTIC ACID SALT | CRITICAL THERAPEUTICS, INC. (US) | 2003-10-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190077743-A1 | FRUITY ODORANT | C5, TAS1R3, TAS1R1 | ALDH1A1 142/4885LMNA 4290/4885HSD17B10 1749/4885 |
| US-20030232884-A1 | New pharmaceutical formulation | LIPA, CEL, LDHA | ALDH1A1 227/4885LMNA 1853/4885HSD17B10 311/4885 |
| US-20180208540-A1 | FRUITY ODORANT | C5, TAS1R3, TAS2R1 | ALDH1A1 266/4885LMNA 4119/4885HSD17B10 1886/4885 |
| US-20110097291-A1 | FRUITY ODORANT | C5, TAS1R3, TAS2R1 | ALDH1A1 171/4885LMNA 4128/4885HSD17B10 1824/4885 |
| US-10766850-B2 | Fruity odorant | C5, TAS1R3, TAS1R1 | ALDH1A1 142/4885LMNA 4290/4885HSD17B10 1749/4885 |
| US-10246402-B2 | Fruity odorant | C5, TAS1R3, TAS2R1 | ALDH1A1 266/4885LMNA 4119/4885HSD17B10 1886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.